DMAT
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy (LGMD R2) in the RF (NCT04824040) | Artgen Biotech | 2020-01-15 |
Track DMAT automatically
Every clearance here is in the API, with alerts when new ones post.